H
Harvest
Tax-loss replacement research
OGN
Organon & Co.
Health Care›Pharmaceuticals›Pharmaceuticals
30 stocks · 12 ETFs
data as of Oct 9, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for OGN

Among the 30 Pharmaceuticals peers screened, COLL (Collegium Pharmaceutical, Inc.) has tracked OGN most closely over the past year, with a return correlation of 0.17. The strongest fund stand-in is XPH (SPDR S&P Pharmaceuticals) at 0.14 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
COLLCollegium Pharmaceutical, Inc.Pharmaceuticals0.170.190.19—
NVONovo NordiskPharmaceuticals0.160.140.18—
AMPHAmphstar Pharmaceuticals, Inc.Pharmaceuticals0.110.160.16—
PRGOPerrigoPharmaceuticals0.100.180.22—
ZTSZoetis Inc.Pharmaceuticals0.090.190.23—
PAHCPhibro Animal HealthPharmaceuticals0.090.180.21—
ELANElancoPharmaceuticals0.070.160.21—
CORTCorcept Therapeutics IncorporatedPharmaceuticals0.060.120.14—
PBHPrestige Consumer HealthcarePharmaceuticals0.060.140.15—
PFEPfizer Inc.Pharmaceuticals0.050.230.22—
ANIPANI Pharmaceuticals, Inc.Pharmaceuticals0.050.100.13—
ALKSAlkermes plcPharmaceuticals0.040.190.19—
AMRXAmneal PharmaceuticalsPharmaceuticals0.040.180.18—
AZNAstraZenecaPharmaceuticals0.040.200.23—
PCRXPacira BioSciences, Inc.Pharmaceuticals0.040.070.11—
BMYBristol-Myers SquibbPharmaceuticals0.030.200.22—
PTCTPTC Therapeutics, Inc.Pharmaceuticals0.030.150.16—
SNYSanofi S.A.Pharmaceuticals0.030.200.20—
INVAInnoviva, Inc.Pharmaceuticals0.030.100.14—
LQDALiquidia CorporationPharmaceuticals0.030.040.05—
INDVIndiviorPharmaceuticals0.030.130.01—
LLYEli LillyPharmaceuticals0.030.140.18—
SUPNSupernus Pharmaceuticals, Inc.Pharmaceuticals0.010.140.18—
GSKGSK plcPharmaceuticals0.010.200.21—
MRKMerck & Co.Pharmaceuticals0.000.160.18—
JAZZJazz PharmaceuticalsPharmaceuticals-0.010.190.23—
VTRSViatrisPharmaceuticals-0.010.250.27—
ACADAcadia PharmaceuticalsPharmaceuticals-0.020.150.15—
JNJJohnson & JohnsonPharmaceuticals-0.050.150.19—
ABBVAbbVie Inc.Pharmaceuticals-0.070.150.17—
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.140.350.39—
XHESPDR S&P Health Care EquipmentMedical Devices (Equal Wt)SUB-IND0.090.300.33—
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.080.330.38—
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.060.290.35—
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.050.300.32—
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.040.260.27—
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.030.220.29—
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.030.290.34—
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.030.290.34—
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.030.290.34—
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.020.270.32—
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY-0.010.160.22—
NEXT STEPS

Harvesting a loss in OGN?

RELATED

Replacement research for OGN's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.